Report of the Working Party Group for Patient Selection and Preparation

Black, Henry R.; Bourgoignie, Jacques J.; Pickering, Tony; Svetkey, Laura P.; Saddler, M C; Setaro, John F.; Textor, S. C.

doi:10.1093/ajh/4.12.745s

Cited by 18 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We offer the following recommendations, based on the observations of the International Consensus Committee on Captopril Renography and subsequent pivotal studies, regarding how to prepare the patient, select the radionuclide, and interpret the results. 19 " 21 Patients undergoing captopril renography should be well hydrated and ingest an unrestricted salt diet, but they do not need to discontinue their antihypertensive medications before the study, except for ACE inhibitors. After the baseline blood pressure is measured, captopril (25 to 50 mg by mouth, crushed) is administered and a renogram is obtained using either technetium-99m-diethylenetriaminepenta-acetic acid (Tc-DTPA), technetium-99m-mercaptoacetyltriglycine (Tc-MAG3), or OIH.…”

Section: Captopril Renographymentioning

confidence: 99%

Advances in noninvasive screening for renovascular disease

Nally¹,

Olin²,

Lammert³

1994

Cleveland Clinic Journal of Medicine

View full text Add to dashboard Cite

• BACKGROUND Nearly 50 million Americans have hypertension, and renovascular hypertension accounts for perhaps 1% of them. • PURPOSE To review the current recommendations and the available screening tests for renovascular hypertension. • SUMMARY The presence of clinical clues increases the predictive value of screening tests for renovascular hypertension; these include abrupt onset of hypertension before age 30 or after age 55, severe hypertension, accelerated or malignant hypertension, hypertension refractory to a triple-drug regimen, moderate hypertension with diffuse vascular disease, an epigastric bruit, moderate hypertension with unexplained azotemia, and azotemia induced by an angiotensin-converting enzyme inhibitor. Captopril renography and duplex ultrasonography are clinically useful screening tools, but wide variation in accuracy exists among institutions. Magnetic resonance angiography may emerge as an effective clinical test. • CONCLUSIONS A thorough history and physical examination, coupled with judicious use of available screening technology, can help determine if a patient has renovascular hypertension and may benefit from intervention.

show abstract

Section: Captopril Renographymentioning

confidence: 99%

Advances in noninvasive screening for renovascular disease

Nally¹,

Olin²,

Lammert³

1994

Cleveland Clinic Journal of Medicine

View full text Add to dashboard Cite

show abstract

The place of renal scintigraphy in the diagnosis of renal artery stenosis. Fifteen years of clinical experience

Jaarsveld

Krijnen

Derkx

et al. 1997

Archives of Internal Medicine

View full text Add to dashboard Cite

The diagnostic accuracy of renal scintigraphy has not been improved by the introduction of mertiatide or by the use of captopril. The usefulness of scintigraphy as a diagnostic test for the presence of renal artery stenosis remains questionable. The physician will always confront either a substantial number of arteriograms that do not show abnormalities when renal scintigraphy is omitted as a screening step or a substantial number of missed diagnoses when a renal scan that shows abnormalities is used as a prerequisite for arteriography.

show abstract

Comparison of Two Noninvasive Screening Tests for Renovascular Hypertension

Elliott¹

1993

Arch Intern Med

View full text Add to dashboard Cite

In selected, treated patients with a high probability of renovascular hypertension, the renal scintigram with angiotensin-converting enzyme inhibitor was a more accurate noninvasive screening test than the captopril challenge test. Noninvasive screening tests for renovascular hypertension can help to identify patients who should undergo angiography and often predict success after revascularization.

show abstract

Report of the Working Party Group for Patient Selection and Preparation

Abstract: Captopril renography is a valuable test in the diagnosis of patients with renal artery stenosis. We examined the criteria for selecting patients for this procedure and the best methods for preparing the patient for renography.

Cited by 18 publications

References 0 publications

Advances in noninvasive screening for renovascular disease

Advances in noninvasive screening for renovascular disease

The place of renal scintigraphy in the diagnosis of renal artery stenosis. Fifteen years of clinical experience

Comparison of Two Noninvasive Screening Tests for Renovascular Hypertension

Contact Info

Product

Resources

About